Boehringer Ingelheim

Founded in 1885, Boehringer Ingelheim is a global pharmaceutical company headquartered in Germany. It focuses on researching, developing, manufacturing, and marketing innovative healthcare products for humans and animals, with a commitment to improving health and quality of life.

Anjan Chatterjee

Corporate Vice President

Yifang Cui

Investor

Niklas Czeloth

Investor

Kanad Das

Investor

Christian Eckermann

SVP, Head of Biopharma Austria

Alexander Ehlgen

Investor

Mia Hu

Associate

Frank Kalkbrenner

Investor

Julia Kaufman Ph.D

Investment Director, Therapeutics Investment

Sebastian Kreuz

Managing Director

Detlev Mennerich Ph.D

Senior Investment Manager

Philipp Mueller

Investor

Philipp Müller Ph.D

Executive Director and Investment Manager, Therapeutics Investment Team

Philipp Müller

Executive Director

Mark Ralph

Investor

Oliver Reuss Ph.D

Executive Director and Investment Manager, Digital Health Investment

Fei Shen

Managing Director

Arun Thachi

Director

Clive Wood

Senior Vice President

Johannes Zanzinger Ph.D

Investor, Therapeutics Investment

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.